The beneficial antiinflammatory effect of dexamethasone administration prior to reperfusion on the viability of cold-stored skin flaps

International Journal of Tissue Reactions

Volumn 21, Issue 3, 1999, Pages 71-78

  Willemart, G ^b   Knight, Kenneth R ^a   Ayad, M ^b   Wagh, M ^b   Morrison, W A ^b  

^a ST VINCENT S HOSPITAL   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; MYELOPEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CRYOPRESERVATION; DRUG EFFECT; DRUG MECHANISM; ISCHEMIA; MALE; NONHUMAN; RAT; REPERFUSION INJURY; SKIN EDEMA; SKIN FLAP; SKIN PROTECTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CRYOPRESERVATION; DEXAMETHASONE; MALE; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SKIN; SKIN TRANSPLANTATION;

EID: 0033391696     PISSN: 02500868     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Becker M., Lassner F., Krause-Bergmann A., Berger A. Time limits in microreplantation. In: Pho R.W.H., Pereira, B.P., Kumar V.P., Kueh K.A., Satku K., King, L.H., (Eds.). Proc. 12th Symp. Int. Soc. Reconstructive Microsurg. (Singapore, 6-10 Feb., 1996) p. 425.
2. Wei F-C., Chang Y.-L., Chen H.-C., Chuang C.-C. Three successful digital replantations in a patient after 84, 86, and 94 hours of cold ischemia time. Plast. Reconstr. Surg., 82, 346, 1988.
3. Iglesias M., Serrano A. Replantation of amputated segments after prolonged ischemia. Plast. Reconstr. Surg., 85, 425, 1990.
4. Angel M.F., Mellow C.G., Knight K.R., O'Brien, B.McC. Secondary ischemia time in rodents: Contrasting complete pedicle interruption with venous obstruction. Plast. Reconstr. Surg., 85, 789, 1990.
5. Hayden B., Soderberg R., Zarem H., Chaudhuri G. Salvage of ischemic rabbit ear by BW-755c and steroids, but not by indomethacin. Prostaglandins, 33, 63, 1987.
6. Zarem H.A., Hayden B., Soderberg R., Ringham J.M., Gabriel K. Effect of corticosteroid in ischemia-ischemic injury. Plast. Reconstr. Surg., 82, 865, 1988.
7. Mendelson B.C., Woods J.E. Effect of corticosteroids on the surviving length of skin flaps in pigs. Br. J. Plast. Surg., 31, 293, 1978.
8. Mes L.G. Improving flap survival by sustaining cell metabolism within ischemic cells: A study using rabbits. Plast. Reconstr. Surg., 65, 56, 1980.
9. Dolan W.D., Kerr D., Schneiderman T., Arena S. Reducing ischemia-reperfusion injury in rat island groin flaps using dexamethasone. Ann. Plast. Surg., 35, 285, 1995.
10. Dolan W.D., Kerr D., Arena S. Improved reflow and viability in reperfused ischemic rat island groin flaps using dexamethasone. Microsurgery, 16, 86, 1995.
11. Shin M.-S., Angel M.F., Im M.J., Manson P.N. Effects of 21 aminosteroid U74389F on skin-flap survival after secondary ischemia. Plast. Reconstr. Surg., 94, 661, 1994.
12. Kerrigan C.L., Daniel R.K. Critical ischemia time and the failing skin flap. Plast. Reconstr. Surg., 94, 69, 1982.
13. Lange K., Boyd L.J. The use of fluorescein to determine the adequacy of the circulation. Med. Clin. North Am., 26, 943, 1942.
14. Sasaki G.H., Pang C.Y. Experimental evidence for involvement of prostaglandins in viability of acute skin flaps: Effects on viability and mode of action. Plast. Reconstr. Surg., 67, 335, 1981.
15. Gavrieli Y., Sherman Y., Ben Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol., 119, 493, 1992.
16. Hickey M.J., Hurley J.V., Angel M.F., O'Brien B.McC. The response of the rabbit rectus femoris muscle to ischemia and reperfusion. J Surg. Res., 53, 369, 1992.
17. Kohout M., Lepore D.A., Knight K.R. et al. Cool preservation solutions for skin flaps: A new mixture of pharmacological agents which improves skin flap viability. Br. J. Plast. Surg., 48, 132, 1995.
18. Wollf S.P. Ferrous ion oxidation in presence of ferric ion indicator xylenol orange for measurement of hydroperoxides. Meth. Enzymol., 105, 182, 1994.
19. Donski P.K., Franklin J.D., Hurley J.V., O'Brien B.McC. The effect of cooling on experimental free flap survival. Br. J. Plast. Surg., 33, 353, 1980.
20. Chiu H.-Y., Chen M.-T. Revascularisation of digits after thirty-three hours of warm ischemia time: A case report. J. Hand Surg., 9, 63, 1984.
21. Baek S.-M., Kim S.-S. Successful digital replantation after 42 hours of warm ischemia. J. Reconstr. Microsurg., 8, 455, 1992.
22. Report of the American Replantation Mission to China. Replantation surgery in China. Plast. Reconstr. Surg., 52, 476, 1973.
23. Kerrigan C.L., Stotland M.A. Ischemia/reperfusion injury: A review. Microsurgery, 14, 165, 1993.
24. Willemart G., Knight K.R., Morrison W.A. Dexamethasone prior to reperfusion improves the survival of skin flaps subjected to secondary venous ischemia. Br. J. Plast. Surg., 51, 624, 1998.
25. Flower R.J. Lipocortin and the mechanism of action of the glucocorticoids. Br. J. Pharmacol., 94, 987, 1988.
26. Campbell W.B. Lipid-derived autacoids: Eicosanoids and platelet-activating factor. In: Gillman A.G., Rail T.W., Nies A.S., Taylor P., (Eds.). "Goodman & Gillman's The Pharmacological Basis of Therapeutics, Volume 1". Pergamon Press, New York, 1991, pp. 600-617.
27. Masferrer J.L., Reddy S.T., Zweifel B.S., et al. In vivo glucocorticoids regulate cyclooxygenase-2 but not cyclooxygenase-1 in peritoneal macrophages. J. Pharmacol. Exp. Ther., 270, 1340, 1994.
28. Douglas B., Weinberg H., Song Y., Silverman D.G. Beneficial effects of ibuprofen on experimental microvascular free flaps: Pharmacologic alteration of the no-reflow phenomenon. Plast. Reconstr. Surg., 79, 366, 1987.
29. Feng L.J., Berger B.E., Lysz T.W., Shaw W.W. Vasoactive prostaglandins in the impending no-reflow state: Evidence for a primary disturbance in microvascular tone. Plast. Reconstr. Surg., 81, 755, 1988.
30. Mellow C.G., Knight K.R., Angel M.F., O'Brien B.McC. The effect of thromboxane synthetase inhibition on tolerance of skin flaps to secondary ischemia caused by venous obstruction. Plast. Reconstr. Surg., 86, 329, 1990.
31. Yarwood H., Nourshargh S., Brain S., Williams T.J. Effect of dexamethasone on neutrophil accumulation and edema formation in rabbit skin: An investigation of site of action. Br. J. Pharmacol., 108, 959, 1993.
32. Breidahl A.F., Hickey M.J., Stewart A.G., Hayward P.G., Morrison W.A. Effects of low dose intra-arterial monoclonal antibodies to ICAM-1 and CD11/CD18 on ischaemia reperfusion injury in the rabbit rectus femoris muscle. Br J. Plast. Surg., 49, 202, 1996.
33. Tessier P.A., Cattaruzzi P., McColl S.R. Inhibition of lymphocytes adhesion to cytokine-activated synovial fibroblasts by glucocorticoids involves the attenuation of vascular cell adhesion molecule 1 and intercellular adhesion molecule 1 gene expression. Arth. Rheum., 39, 226, 1996.
34. Aziz K.E., Wakefield D. Modulation of endothelial cell expression of ICAM-1, E-selectin, and VCAM-1 by beta-oestradiol, progesterone and dexamethasone. Cell. Immunol., 167, 79, 1996.
35. Cronstein B.N., Kimmel S.C., Levin R.I., Martiniuk F., Weissmann G. A mechanism for the anti-inflammatory effects of corticosteroids: The glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule-1. Proc. Natl. Acad. Sci. USA., 89, 9991, 1992.
36. Knight K.R., Angel M.F., Lepore D.A., et al. Secondary ischaemia in rabbit skin flap: The roles played by thromboxane and free radicals. Clin. Sci., 80, 235, 1991.
37. Angel M.F., Mellow C.G., Knight K.R., O'Brien, B.McC. The effect of deferoxamine on tolerance to secondary ischemia caused by venous obstruction. Br. J. Plast. Surg., 42, 422, 1989.
38. Lee C., Kerrigan C.L., Tellado J.M. Altered neutrophil function following reperfusion of an ischemic myocutaneous flap. Plast. Reconstr. Surg., 89, 916, 1992.
39. 2 production by human recombinant lipocortin 1. Br. J. Pharmacol., 93, 139, 1988.
40. Hess M.L., Manson N.H. The paradox of steroid therapy: Inhibition of oxygen free radicals. Circ. Shock, 10, 1, 1983.
41. Stewart A.G., Phan L.H., Grigoriadis G. Physiological and pathophysiological roles of nitric oxide. Microsurgery, 15, 693, 1994.
42. Beckman J.S., Beckman T.W., Chen J., Marshall P.A., Freeman B. A. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA, 87, 1620, 1990.
43. Knox L.K., Stewart A.G., Hayward P.G., Morrison W.A. Nitric oxide synthase inhibitors improve skin flap survival in the rat. Microsurgery. 15, 708, 1994.
44. McCall T., Palmer R.M., Moncada S. Induction of nitric oxide synthase in rat peritoneal neutrophils and its inhibition by dexamethasone. Eur. J. Immunol., 21, 2523, 1991.
45. Zhang B., Knight K.R., Dowsing B., et al. Timing of administration of dexamethasone or the nitric oxide synthase inhibitor, nitro-L-arginine methyl ester, is critical for effective treatment of ischaemia-reperfusion to rat skeletal muscle. Clin. Sci., 93, 167, 1997.
46. Barker J.E., Stewart A.G., Knight K.R. , Morrison W.A. Lack of inducible NOS expression attenuates the pathogenesis of ischaemia reperfusion injury. Proc. Xth Int. Vasc. Biol. Meeting. (Cairns. 23-27 August, 1998) p. 89.